Lipocine files Form 3 initial beneficial ownership statement for director Michael Grissinger
LPCN•Form 3 filing for new director
Lipocine director Michael Grissinger filed an initial Form 3 on Aug. 7 tied to an Aug. 3 reporting event.
Related News
TriCo Bancshares Q2 FY26 net income rises 24.1% to $34.17 million; net interest margin widens 23 bps to 4.11%
TCBK•
Expion360 Q2 gross margin rises as product mix shifts to higher-margin items
XPON•
United Parks Q2 FY26 net income drops 21% to 63.27 million; revenue falls 1.4% to 483.32 million
PRKS•
Cardio Diagnostics Q2 FY26 net loss narrows to $1.5 million; revenue falls to $5,360
CDIO•
Liquidity Services posts Q3 adjusted EBITDA up 30% to USD 22 million, targets USD 2 billion annual GMV, CEO says
LQDT•